Lonneke J. Verboon

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Journal: Blood advances
Published: October 20, 2025

DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia.

DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia.

Journal: Blood advances
Published: October 20, 2025

Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15.

Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15.

Journal: iScience
Published: October 19, 2022

RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia.

RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia.

Journal: Blood
Published: June 29, 2022

The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.

The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.

Journal: Blood advances
Published: January 22, 2019

PHF6 mutations in paediatric acute myeloid leukaemia.

PHF6 mutations in paediatric acute myeloid leukaemia.

Journal: British journal of haematology
Published: November 26, 2016

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.

Journal: Oncotarget
Published: October 27, 2016

Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.

Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.

Journal: Nature genetics
Published: September 14, 2016

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.

Journal: Oncotarget
Published: February 28, 2016

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.

Journal: Haematologica
Published: January 18, 2015

Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia.

Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia.

Journal: Haematologica
Published: May 13, 2014

miR-9 is a tumor suppressor in pediatric AML with t(8;21).

miR-9 is a tumor suppressor in pediatric AML with t(8;21).

Journal: Leukemia
Published: May 02, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026